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Editorial: The Whipple Bacillus Lives (Ex Vivo)! 
David A. Relman Departments of Microbiology S. Immunology and of Medicine, Stanford 
University School of Medicine, Stanford, and Veterans Affairs Palo Alto 
Health Care System, Palo Alto, California 
Cultivation of the bacillus associated with Whipple's disease, 
Tropheryma whippelii, has been an elusive goal for many gen- 
erations of clinicians and microbiologists familiar with this 
disease. The desire to identify this enigmatic organism has 
motivated many of these efforts. Many purported successes 
have later proven erroneous, and many more unsuccessful at- 
tempts have never been reported [1]. Cell-free media, animal 
cells, and animals themselves have all been used, resulting in 
recovery of a wide range of bacterial species, including mem- 
bers of the Corynebacterium, Streptococcus, Propionibacte- 
rium, and Haemophilus genera. The rough resemblance ofRho- 
dococcus equi- , Mycobacterium paratuberculosis- , and 
Mycobacterium avium complex-associated diseases in foals, 
cows, and humans, respectively, to Whipple's disease has been 
noted; however, pathology closely mimicking that of the latter 
has never been knowingly and intentionally transferred to an- 
other human nor reproduced in a nonhuman host. Despite the 
unusual cell wall features of this bacillus and its reactivity to 
the periodic acid-Schiff (PAS) reagent [2], the absence of 
a specific microbial signature has greatly hindered efforts to 
evaluate these previous cultivation efforts. 
Over the past 10 years, there has been a fundamental change 
in the approach to microbial identification and taxonomy. This 
change involves a decreasing reliance on cultivated organisms 
and their associated phenotypes, such as morphology, antige- 
nicity, and biochemical activities, and an increasing reliance 
on genotype, that is, nucleic acid sequences [3, 4]. Certain 
genes, such as that of the small subunit ribosomal RNA (ssu 
rDNA), accurately reflect the evolutionary history of the entire 
genome and allow one to determine the relationships of any 
given organism with all others. By taking advantage of inter- 
spersed, highly conserved portions of these genes, one can 
amplify the intervening, phylogenetically useful sequence di- 
rectly from infected clinical specimens and identify a pre- 
viously uncharacterized or novel microbial pathogen [5, 6]. 
With this "broad-range polymerase chain reaction" (PCR) 
method, a unique, previously unrecognized bacterial ssu rDNA 
sequence was amplified from multiple independent Whipple's 
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disease tissues [7, 8]. Phylogenetic analysis of this sequence 
suggested that the Whipple bacillus is an actinomycete and 
prompted the proposal of a new taxon, Tropheryma whippelii 
[8]. The T. whippelii ssu rDNA sequence now provides the 
basis for a specific PCR detection assay [8-11]. Armed with 
this diagnostic tool, Schoedon et al. [12] have tested a clever 
approach for in vitro Whipple bacillus propagation. The out- 
come of host infection depends in part upon a complex, local 
interplay of immune effector cells and cytokines. Pathogens 
often manipulate these host immune responses to render the 
local environment more hospitable and to enhance their sur- 
vival or dissemination [13]; one strategy is to alter the local 
ThlZTh2 helper T cell profile. Suppression of tumor necrosis 
factor-a or interferon (IFN)-y-mediated macrophage activa- 
tion is a common strategy for microorganisms that choose an 
intracellular niche. Might one mimic this strategy by treating 
macrophages with cytokines or hormones that deactivate mi- 
crobicidal pathways but preserve phagocytosis and thereby pro- 
mote replication of an organism in a protected intracellular 
compartment? Interleukin (IL)-4, IL-10, and dexamethasone 
have been shown to enhance intracellular growth of certain 
pathogens within human macrophages by suppressing both oxi- 
dative and nonoxidative killing mechanisms but without inhib- 
iting bacterial uptake [14, 15]. Schoedon et al. have taken this 
same approach for cultivating the Whipple bacillus. In this 
issue of the Journal, they provide evidence that T whippelii 
replicates in the laboratory within human peripheral monocyte - 
derived macrophages, as well as within a macrophage-like cell 
line, when these host cells are treated with IL-4 [12]. 
The potential ramifications of these findings by Schoedon et 
al. are extensive. Yet, given the long and frustrating history of 
this disease and organism, one must evaluate this report care- 
fully. In the absence of direct bacterial quantification and any 
obvious extracellular growth in vitro, how strong is the evi- 
dence for microbial replication? The authors relied on two 
types of data: (1) an increase in both the percentage of cells 
with visible PAS-positive inclusions and in the number of in- 
clusions per cell and (2) PCR-based detection of T. whippelii 
DNA sequences after a number of cell passages sufficient to 
eliminate DNA detection after an equivalent inoculum dilution 
alone, that is, 100- to 1000-fold (in the absence of host cells). 
In theory, the first type of data might be explained in part by 
more rapid death of uninfected host cells (leading to an increase 
in the percentage of PAS-positive cells), although this seems 
unlikely, and by intracellular edistribution and trafficking of 
PAS-positive bacterial cell wall. PAS reactivity is difficult to 
quantitate and is only an indirect marker of bacterial number. 
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However, quantitative PCR methods with internal standards 
would provide a more direct and reliable assessment of bacte- 
rial growth in this situation [16]. 
The exact identity of the organism propagated in this study is 
another crucial issue. Heart-valve tissue with apparently typical 
Whipple's disease pathology, from 2 persons, served as the 
inocula for cultivation [12]. From each tissue sample, a partial 
bacterial 16S rDNA fragment was amplified using broad-range 
PCR, from which ?400 bp of sequence was determined. Al- 
though these sequences were nearly identical to the correspond- 
ing segment of the previously published T. whippelii 16S rDNA 
sequence [8], this amount of primary sequence information is 
less than desirable. At various stages of tissue cocultivation, a 
T whippelii PCR-based assay was positive, but the details of 
assay specificity are not provided. For the purpose of species, 
and certainly strain, identification, a complete 16S rDNA se- 
quence is probably a minimum requirement; in most cases, 
additional sequence information from more rapidly evolving 
genetic loci is necessary. Nonetheless, it appears quite likely 
that the organism propagated by Schoedon et al. is either 
T. whippelii or a close relative. 
What have we learned about the Whipple bacillus and its 
host from the results of this study? Might we have anticipated 
these findings from information previously available concern- 
ing this organism and its associated disease? First of all, 
T. whippelii appears to have a particular affinity for human 
macrophages and macrophage-like cells. Perhaps it is no coin- 
cidence that this organism elicits a prominent macrophage re- 
sponse during natural infection. Whether or not T. whippelii 
warrants the designation as an "intracellular pathogen," how- 
ever, is unclear. The cell cocultivation conditions chosen by 
Schoedon et al. may have biased the outcome toward intracellu- 
lar survival and growth and may not have provided the bacte- 
rium with the extracellular conditions that it encounters and 
prefers in a susceptible host. The pathology of Whipple's dis- 
ease is notable for numerous intact extracellular bacilli, with 
some undergoing binary fission; at the same time, most bacilli 
within macrophages are at least partially degraded [1]. The 
same observation was made by Schoedon et al. in vitro, despite 
the macrophage-inactivating effects of IL-4 [12]. Second, the 
Whipple bacillus is at least microaerophilic. Third, the require- 
ment for IL-4 treatment of macrophages draws attention to the 
possibility of a host cellular immune defect and the potential 
role of a polarized Th2 cytokine profile. Bjerknes and col- 
leagues [17, 18] have suggested that monocytes and macro- 
phages from Whipple's disease patients exhibit deficient micro- 
bial degradation capabilities. On the other hand, the effects of 
IL-4 are pleiotropic and nonspecific; the link between a Whip- 
ple's disease host defect and IL-4 may be only indirect. In 
theory, IFN-y and its receptor are also possible key players in 
host susceptibility to this disease. Finally, did phylogeny pre- 
dict physiology? When the relevant branch of the evolutionary 
tree is robust, microbial phylogeny sometimes predicts pre- 
ferred growth conditions; however, because there are few 
known close relatives of T whippelii, such insights would have 
been difficult to discern. 
In an era of decreasing reliance on cultivated organisms and 
increasing reliance on rapid and specific molecular or sequence- 
based methods for microbial characterization, what is the value 
of propagating an organism such as the Whipple bacillus in 
the laboratory? With phylogenetically useful sequence alone, 
microbial identification and evolutionary analysis are possible; 
predictions can be made regarding metabolic, biochemical, and 
virulence-associated activities and then further evaluated with 
consensus PCR and sequencing; growth state might be esti- 
mated from quantitative rRNA measurements; and compelling 
arguments can be developed for a role in disease causation 
[19]. To the degree that additional genome sequence informa- 
tion may be further revealing, one might "walk" the chromo- 
some of an uncultivated microorganism beginning with the ssu 
rDNA [20]; it may even be possible to determine a complete 
genome sequence from such organisms with shotgun cloning 
methods and powerful sequence assembly algorithms. How- 
ever, the advantages of a laboratory propagated organism are 
still substantial. 
A viable microorganism, provided with relevant growth con- 
ditions, readily reveals its metabolic and virulence capabilities. 
Disease models and correlates of pathogenicity can be estab- 
lished. Laboratory propagation creates substantial amounts of 
pure microbial cell mass, with which serologic assays can be 
developed, monoclonal antibodies elicited, and chromosomal 
DNA easily prepared. From recombinant chromosomal ibrar- 
ies, virulence-associated genes can be isolated, and the molecu- 
lar mechanisms of disease causation can be explored. Immuno- 
dominant antigens can be cloned and expressed. Diagnosis can 
then be based on whole cell- or recombinant antigen-based 
serologic assays or on specific immunochemical and immuno- 
fluorescent issue hybridization. Microbial drug susceptibility 
can be assessed in vitro. Recombinant antigens may be protec- 
tive for susceptible hosts. 
In theory, all of these advantages can now be realized for 
T. whippelii. In practice, several issues will first need to be 
addressed. The organism propagated by these authors should 
be characterized in greater detail. Optimization of growth con- 
ditions leading to consistent, high-titer culture yields will be 
important. One approach might involve cell lines bearing trans- 
genes or genetic defects that render them hypersusceptible to 
T whippelii growth. Intracellular bacterial degradation needs 
to be minimized. And, of course, the findings reported herein 
need to be reproduced by others. But if this work is substanti- 
ated, Schoedon and colleagues will have made a key contribu- 
tion to a fascinating 90-year saga in clinical microbiology. No 
microorganism is uncultivatible; the real issue is whether we 
are intelligent enough to understand the sometimes complex 
and intimate growth requirements of our prokaryotic cousins. 
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